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We testedwhether double cortin-like kinase-short (DCLK-short), a microtubule-associated Ser/Thr
kinase predominantly expressed in the brain, is downstream of the ERK signaling pathway and is
involved inproopiomelanocortingene (POMC)expression inendocrinepituitarymelanotrope cells
of Xenopus laevis. Melanotropes form a well-established model to study physiological aspects of
neuroendocrine plasticity. The amphibian X. laevis adapts its skin color to the background light
intensity by the release of -MSH from the melanotrope cell. In frogs on a white background,
melanotropes are inactive but they are activated during adaptation to a black background. Our
results show that melanotrope activation is associated with an increase in DCLK-short mRNA and
with phosphorylation of DCLK-short at serine at position 30 (Ser-30). Upon cell activation phos-
phorylated Ser-30-DCLK-short was translocated from the cytoplasm into the nucleus, and the ERK
blocker U0126 inhibited this process. The mutation of Ser-30 to alanine also inhibited the trans-
locationand reducedPOMCexpression,whereasoverexpression stimulatedPOMCexpression. This
is the first demonstration of DCLK-short in a native endocrine cell. We conclude that DCLK-short
is physiologically regulated at both the level of its gene expression and protein phosphorylation
and that the kinase is effectively regulating POMC gene expression upon its ERK-mediated
phosphorylation. (Endocrinology 152: 2321–2329, 2011)
Double cortin-like kinase-short (DCLK-short), one ofthe splice variants of theDCLK1 gene, is abundantly
expressed in the adult rodent brain (1, 2). DCLK1 is a
member of the double cortin (DC) gene family. Proteins
encodedby this family are characterized by the presence of
tubulin-binding domain, the so-called DC domain (for re-
view see Ref. 3). DCLK1-derived proteins containing DC
domains, like DCLK-long and DC-like, play well-estab-
lished roles in neurogenesis and neuronalmigration (4, 5).
In contrast, the function of DCLK-short, aDCLK1 splice
variant that lacks DC domains and encodes a Ser/Thr ki-
nase (6), is less well known. Physiological importance of
DCLK is suggested by the fact that it is evolutionary well
conserved, occurring in both fish and mammals (7, 8). It
is hypothesized to play a role in neuronal plasticity (9)
because it is abundant in the hippocampus, and its gene
expression is enhanced in the dentate gyrus upon kainate
treatment (2, 6). This hypothesis is supportedby the recent
demonstration that all short DCLK1 variants are up-reg-
ulated during brain-derived neurotrophic factor (BDNF)-
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induced synapse consolidation (10). The N-terminus of
DCLK-short possesses a serine- and proline-rich domain
that contains the aminoacid sequence PTSP, a target of the
main component of growth factor signaling pathways,
ERK (11, 12). Furthermore, the catalytic domain of
DCLK-short contains the nuclear targeting motif RRRR
at positions 393–396 (6), suggesting involvement of this
kinase in the regulation of gene expression. When trans-
fected into theCOS-7 cell line, someDCLK is translocated
from the cytoplasm into the nucleus after its cAMP-de-
pendent phosphorylation (13), but whether its ERK phos-
phorylation site is involved in this process is not known.
DCLK-short is present in not only neurons but also the
endocrine cell-derived PC12 cell line (14). However, up to
now, the kinase has not been shown in a native endocrine
cell. Therefore, in the present study, we investigated its
presence in the endocrine melanotrope cells in the pitu-
itary pars intermedia of the amphibian Xenopus laevis.
We further studied the regulation and the actionofDCLK-
short in these cells in relation to the animal’s physiology.
Melanotrope cells promote pigment dispersion in dermal
melanophores of Xenopus by releasing MSH when an-
imals are adapting to a black background. Melanotropes
are inactive in toads on a white background but are
strongly activated during adaptation to a black back-
ground. The melanotrope cell displays high plasticity be-
cause this activation involves a strong increase in cell size
and an up-regulation of genes involved in the production,
processing, and secretion of MSH, including POMC, the
gene of its precursor protein proopiomelanocortin (POMC)
(15–17). These events are coordinated by several intracellu-
lar signaling cascades, including the ERK signaling pathway
(17, 18). The simplicity of this physiological activation pro-
cess together with the involvement of the ERK signaling
pathway makes the Xenopus melanotropes an ideal exper-
imental model to study the regulation and the function of
DCLK-short in a native endocrine system.
In this studywe tested our hypothesis that DCLK-short
is present in endocrinemelanotrope cells, is regulated dur-
ing background adaptation of the animal, and is involved
in the control of POMC mRNA expression as a down-
stream effector of ERK signaling. For this purpose, we
determined the effect of cell activation (by black back-
ground adaptation) on the expression of DCLK-short
mRNA and on the phosphorylation state and cellular dis-
tribution ofDCLK-short protein. Subsequently the role of
ERK in the phosphorylationofDCLK-short at position30
(Ser-30) of the PTSP sequence has been demonstrated and
the subcellular presence of the phosphorylated (p) kinase
(p-DCLK-short) localized. Finally, the contribution of
nuclear phosphorylated double-cortin-like kinase (p-




AdultX. laevis, aged6months,werekeptona12-h light, 12-h
dark cycle (lights on at 0700h) at 22Cand fed a diet of beef heart
and Aquatic 3 (Dietex International,Witham, UK). Background
adaptation was performed by placing animals for different pe-
riods in a black or white container under continuous illumina-
tion; full skin adaptation was achieved after 3 wk. Subsequently
the animals were anesthetized by immersion in 0.1% MS222
(ICN Biomedicals, Aurora, OH), rapidly decapitated, and the
pituitary neurointermediate lobe (NIL) or the whole pituitary
gland together with the brain dissected. For cell transfection
studies, before decapitation, animals were transcardially per-
fusedwithXenopusRinger’s solution (112mMNaCl; 2mMKCl;
2 mM CaCl2; 15 mM Ultra-HEPES; and 0.2% glucose, pH 7.4)
containing 0.025%MS222 to remove blood cells. Animal treat-
ment was in agreement with the Declaration of Helsinki and the
Dutch law concerning animal welfare, as verified by the Com-
mittee for Animal Experimentation of Radboud University
Nijmegen.
Quantitative RT-PCR (Q-RT-PCR)
NIL of 3-wk white-adapted animals, subsequently adapted
for 0, 1, 3, 6, and 24 h to a black background, and animals
adapted for 3 wk to a black background (19) were collected and
homogenized in ice-cold Trizol (Life Technologies, Paisley, UK).
Because the neural lobe contains mainly nerve terminals from
neuronsoriginating in thehypothalamusand the vastmajority of
the cells in the pars intermedia are melanotropes, the extracted
mRNAwill be mainly from themelanotropes located in the pars
intermedia. RNA was extracted with chloroform and precipi-
tated with isopropanol and glycogen. The RNA pellets were
rinsed in ice-cold 75% ethanol, air dried, and resuspended in
ribonuclease (Rnase)-freemilli-Qwater (Millipore, Amsterdam,
Netherlands). The RNA concentration was measured by Nano-
Drop 1000 (Thermo Fischer Scientific, Wilmington, DE). First-
strand cDNAwas synthesized at 70C for 10minwith 0.1gRNA
and 5mU/l randomprimers (Roche,Mannheim,Germany) at 37
C for 75min in first-strand buffer (Life Technologies) with 10mM
dithiothreitol, 20 U Rnasin (Promega, Madison, WI), 0.5 mM de-
oxynucleotide triphosphates (Roche, Almere, The Netherlands),
and 100 U Superscript II reverse transcriptase (Life Technologies)
and finally in the same buffer at 95 C for 10 min.
For single-cell Q-RT-PCR, individual melanotrope cells ex-
hibiting green fluorescent protein (GFP) fluorescence (for cell
preparation, see below) were aspirated in Rnase-free milli Q
water through a glass micropipette with a tip opening of 0.8–1
m and transferred onto a 48 Ampligrid reaction slide (Adva-
lytix, Munich, Germany). After air drying the sample, first-
strand cDNA was synthesized on the slides using the Ampligrid
cycler (Advalytix) in amixture of 0.5mUpd(N)6 randomprimer
(Roche), 0.05 M deoxynucleotide triphosphates (Roche), 1.0
mM dithiothreitol (Invitrogen, Carlsbad, CA), 10 U SuperScript
II reverse transcriptase (Invitrogen), 1 first-strand buffer (In-
vitrogen), and 2.0 U Rnasin (Promega). The mixture was sealed
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off with inert sealing oil (Advalytix). Incubation was at 70 C for
10 min, 37 C for 75 min, 95 C for 10 min, and 30 C for 1 min.
Finally, Rnase-free milli Q water was added and the sample as-
pirated for use in the Q-RT-PCR.
cDNA amplification was carried out with power SYBR Green
PCR master mix (Applied Biosystems, Warrington, UK) and 0.6
M of each primer. The primers for DCLK-short were based on
Silurana tropicalis DCLK1 (accession no. NM_001045640), and
those for POMC and the gene of glyceraldehyde 3-phosphate de-
hydrogenase gene (GAPDH)were basedon the respectiveX. laevis
sequences (accession no. X03843 and U41753, respectively). The
sequences were: DCLK-short forward, 5-CAAGTGAACTC-
TACCTTGTCATGGA-3, reverse, 5-GCTCAGTGTATTTGT-
TGGTCGAAGT-3; POMC forward, 5-AGGGAACGATG-
GAAGCAACA-3, reverse, 5-TGTCACCTGGAGCATTC-
TGATT-3, and GAPDH forward, 5-GCTCCTCTCGCAA-
AGGTCAT-3, reverse, 5-GGGCCATCCACTGTCTTCTG-3.
The temperature cycling protocol consisted of 10 min at 95 C
and 40 cycles of, alternatingly, 15 sec at 95 C and 1 min at 60
C and was run on a 7500 real-time PCR system (Applied
Biosystems).
For single-cell Q-RT-PCR, the same cycling protocol was fol-
lowed but with 50 instead of 40 cycles. In these single-cell ex-
periments cycle threshold (Ct) values of GAPDH, DCLK-short,
and POMC were between 30 and 40 and were corrected by
subtraction of the corresponding Ct values of the gene of the
housekeeping enzyme GAPDH. Samples were included in
the analysis only if the melting curve was at its maximum at the
predicted melting temperature and a product with the correct
molecular weight showed up on a 1% agarose gel.
DCLK-short alignment
The protein sequences, predicted on the basis of S. tropicalis
DCLK-short transcripts (NP001039105.1) (20),were alignedwith
theknownDCLKsequencesofHomosapiens (BAH12940.1),Mus




In some experiments the location of DCLK-short was studied
in single melanotropes, which were isolated from NIL as de-
scribedpreviously (22). In short,NILwere incubated inXenopus
Ringer’s containing 0.25% trypsin (Sigma-Aldrich, St. Louis,
MO) but without CaCl2, for 45 min at 22 C. Then NIL were
gently triturated and the resulting cell suspension was centri-
fuged at 50 g for 10min. The cell pellet was resuspended inX.
laevis Leibovitz L15 medium consisting of XL-L15, 76% Lei-
bovitz culturemedium(LifeTechnologies), 1%kanamycine, 1%
antibiotic/antimycotic (Life Technologies), 2 mM CaCl2, and 10
mMglucose (pH7.4) for immunocytochemistry and transfection
studies. ForWestern blot analyses, incubationwas in lysis buffer
containing 50 mMHEPES (pH 7.2), 140 nM NaCl, 0.1% Triton
X-100, 1% Tween 20, 1 mM EDTA, 0.1% deoxycholate,
0.0001% pepstatin, 0.0001% leupeptin, 0.0001% aprotinin,
0.0002% phenylmethanesulfonylfluoride, 0.01% benzamidine
(Sigma-Aldrich), and0.0008%calpain I and calpain II inhibitors
(Boehringer, Mannheim, Germany). The pars nervosa of the pi-
tuitary gland, which remained undissociated in this protocol,
was used as control.
Western blot analyses
To determine their DCLK contents, NIL were collected indi-
vidually in ice-cold lysis buffer with 0.2% NaF to inhibit phos-
phatase activity. To establish the involvement of ERK signaling
in DCLK-short phosphorylation before lysis, some NIL were
incubatedwith 100MofMAPKkinase (MEK) inhibitorU0126
(Tocris Bioscience, Bristol, UK) in XL-L15 at 22 C for 1 d.
After 30 min incubation in lysis buffer, NIL and single mela-
notropes were homogenized and centrifuged at 16,000 g at 4
C for 30 min. The supernatant was incubated at 95 C for 5 min
in sample buffer (62.5 mM Tris-HCl; 12.5% glycerol; 1.25%
sodium dodecyl sulfate (SDS); 0.0125% bromophenol blue;
2.5% -mercaptoethanol, pH 6.8). After running samples on a
12% SDS-polyacrylamide gel (Precise protein gels, Thermo Sci-
entific, Rockford, IL) usingBupHTris-HEPES-SDS running buf-
fer (Thermo Scientific), separated proteinswere transferred onto
a polyvinylidene difluoridemembrane (Millipore, Bedford,MA)
using BupH Tris-glycine buffer (Thermo Scientific). Blots were
rinsed in 0.1 M Tris-buffered saline (TBS; pH 7.6) and incubated
in blocking buffer (TBS with 5% milk powder) and in blocking
buffer containing either rabbit polyclonal p-DCLK antiserum
raised against the phosphorylated Ser-30 residue in the PTSP
domain [1:1000 (vol/vol); see below] or rabbit polyclonalDCLK
antiserum [1:1000 (vol/vol)] (23). After rinsing with TBS with
0.2% Tween 20 blots were incubated in goat antirabbit perox-
idase conjugate (1:1000;Nordic, Tilburg, TheNetherlands) and
rinsed again in TBSwith 0.2%Tween 20 andTBS. Proteinswere
visualized by incubation in Supersignal West Pico chemilumi-
nescent substrate solution (Thermo Scientific) using x-ray film
(Fujifilm,Tokyo, Japan).After scanning the film (Scanjet 5590P;
Hewlett Packard, Palo Alto, CA), the average immunostaining
density of the protein bands was expressed as the specific signal
density (SSD), using ImageJ software (version 1.37; National
Institutes of Health, Bethesda, MD) (24).
Immunohistochemistry
The dissected brain and pituitary gland of white- and
black-adapted animals were fixed in Bouin’s fluid for 24 h and
dehydrated in a graded series of ethanol. Paraffin sections of
7 m thickness were mounted on glass slides coated with
poly-L-lysine (Sigma-Aldrich), deparaffinized, rehydrated in a
graded ethanol series, rinsed in 0.1 M sodium PBS (pH 7.6),
treatedwith 0.5%TritonX-100 (SigmaChemical, Zwijndrecht,
The Netherlands) in PBS, rinsed, and preincubated in blocking
buffer containing PBS, 2.5% normal horse serum (Vector Lab-
oratories, Burlingame, CA), 2.5% normal goat serum (Jackson
ImmunoResearch, Suffolk, UK), and skimmed milk. Then sec-
tions were incubated with first antiserum (1:1000 rabbit poly-
clonal p-DCLK) in blocking buffer. After rinsing in PBS, they
were treated with biotin conjugate (1:200; Vector Laboratories)
and rinsed in PBS. Subsequently sections were incubated with
avidine-biotin complex (1:200; Vector Laboratories) and suc-
cessively with 0.05% diaminobenzidine in the Tris buffer for 10
min and with 0.005% H2O2 for about 10 min. The latter reac-
tion was controlled under a stereo microscope and stopped with
Tris buffer. Then sections were rinsed in PBS, dehydrated in
ethanol, coverslipped with Entellan (Merck, Darmstadt, Ger-
many), and examinedwith aNikonMicrophot FXAmicroscope
(Nikon, Tokyo, Japan).
To determine the degree of immunoreactivity of a NIL, the
SSD of the immunoreactive signal was assessed using the ImageJ
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software (National Institutes of Health) at five randomly taken
places in the largest section profile of the pars intermedia. The
SSD of the pars nervosa was determined in the same way.
To study the subcellular location of p-DCLK, melanotrope
cells resuspended in XL-L15 were plated onto poly-L-lysine-
coated, four-chamber-coverglass (Nalge Nunc, Rochester, NY),
fixed in 4% paraformaldehyde for 15 min, rinsed with PBS, and
stained for p-DCLKas described above. After rinsing three times
in PBS, cells were stained for 15 min in 100 nM Hoechst 33258,
washed five more times, and coverslipped with FluorSave and
examined with an LSM2 confocal laser-scanning microscope
(Leica, Wetzlar, Germany) using a63 oil immersion objective
(numerical apperture 1.42) at 350 nm excitation wavelength.
The pinhole size was set at two times the Airy disk, achieving an
optical section resolution along the z-axis of approximately 2 m.
Antiserum specificity
The high specificities of the rabbit polyclonal DCLK antise-
rum have been shown before (5). The rabbit polyclonal p-DCLK
antiserumwas generated against the peptide PSPTpSPGSLRKQ,
corresponding to positions 24–38 of rat DCLK (Eurogentec,
Rotterdam, The Netherlands). Specificity of the antiserum was
demonstrated with ELISA against the native phosphorylated
peptide and, moreover, as follows: point mutation was intro-
duced into mouse wild-type (WT) DCLK-short cDNA in
pcDNA3.1 (Invitrogen) vector using a QuikChange site-di-
rected mutagenesis kit according to the manufacturer’s instruc-
tion (Stratagene, La Jolla, CA), disrupting the potential serine
phosphorylation site of DCLK by replacing serine by alanine
(S/A mutant). As can be seen in Supplemental Figure 1, both
DCLK-short proteins were detected with the DCLK antiserum.
Incubationwith recombinant ERK slows downDCLK-shortmi-
gration (Supplemental Fig. 1A, lanes 1 and 2, published on The
Endocrine Society’s Journals Online web site at http://endo.
endojournals.org) comparedwith control (without ERK; lanes 3
and 4), a result that can be partially explained when the protein
is phosphorylated by ERK. Mutation of Ser-30 to alanine abol-
ishes this particular ERK phosphorylation site so that p-DCLK
cannot react with it (Supplemental Fig. 1B, lane 2).We therefore
conclude that the p-DCLK antiserum recognizes only the Ser-30
phosphorylation site and is a reliable tool to detect p-DCLK.The
epitopes used to generate the antibodies are 100% conserved
between mammals and frogs (Supplemental Fig. 2). Thus, the
antibodies can be used as a reliable tool to demonstrate DCLK
and p-DCLK in frog tissue.
Transfection studies
Single melanotropes in XL-L15 were plated onto poly-L-
lysine-coated, four-chamber coverglasses. After 24 h incubation
in XL-L15 with 10% fetal calf serum (Life Technologies), cells
were transfected with a DCLK-short-GFP construct placed in a
pcDNA 3.1 plasmid (Invitrogen) behind a cyanomegalovirus
promoter. Transfections were performed using 1 g DNA per 5
l lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s protocol. Two DCLK-short-GFP constructs were used,
one with the WT-DCLK-short sequence and the other with the
serine residue at position 30 of the PTSP motif mutated to ala-
nine, creating a nonphosphorylatable PTAP domain (S/A). Con-
trol cells were transfected with an empty vector (EV) only con-
taining GFP. Fluorescence in these control cells was confined to
the cytoplasm (data not shown). After transfection incubation
for 18 h, cells were rinsed, supplied with XL-L15 containing
10% fetal calf serum, and incubated for 4 d while medium was
refreshed daily. Transfection efficiency (percentage of fluores-
cent cells) was between 15 and 25%. For localization of GFP
constructs, cells were incubated with 100 M U0126 (Tocris
Bioscience) for 16h, afterwhichGFP fluorescencewas examined
by confocal laser-scanning microscopy (excitation wavelength
488 nm, emission wavelength 510–580 nm).
Statistics
All data were expressed as mean and SEM per experimental
group. Random sampling procedures were used throughout the
experiments. Data of Western blots and immunocytochemistry
were tested with Student’s t test and the Q-RT-PCR and GFP
construct data with one-way ANOVA followed by Bonferroni’s
post hoc test, using Statistica (StatSoft, Tulsa, OK) (  5%),
after appropriate transformation of the data on the basis of tests
for normality (25) and the homogeneity of variance (Bartlett’s 2
test) (26).
Results
To test our hypothesis thatDCLK-short inXenopusmela-
notropes is involved in the regulation of POMC expres-
sion in an ERK-dependent way, we performed four sets of
experiments.
Experiment 1: analysis of the homology of
Xenopus DCLK-short
DCLK-short is one of the splice variants of theDCLK1
gene, together with DC-like and DCLK-long. In contrast
to DCLK-long, it lacks the N-terminal DC domain (Sup-
plemental Fig. 2A). Because the DNA sequence of DCLK-
short ofX. laevis is unknown, the amino acid sequence of
frog DCLK-short was predicted on the basis of the DNA
sequence of S. tropicalis and aligned with the sequence of
DCLK-short of zebrafish, mouse, and human. This
showed that all DCLK-short have strong similarities to
each other (Supplemental Fig. 2B). Frog DCLK-short has
an 89% amino acid sequence identity with mouse and
human DCLK-short and a 71% sequence identity with its
zebrafish orthologous gene. The N-terminal part of
DCLK-short including the serine- and proline-rich do-
main is identical between frog, mouse, and human. Also,
the nuclear retention sequence RRRR at positions 393–
396 is identical in frog,mouse, andhuman,whereas in fish
only one residue is different (Supplemental Fig. 2B).
Experiment 2: presence and regulation of
DCLK-short
Using Q-RT-PCR, we found that DCLK-short mRNA
is present in the NIL of both white- (inactive melano-
tropes) and black (active melanotropes)-adaptedX. laevis
(Fig. 1). In activemelanotropes the amount ofmRNAwas
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about 4 times higher than in inactive ones (P 0.005; n
5).When animalswere transferred from awhite to a black
background, the first indication of up-regulation was ob-
served after 3 h, and maximum mRNA expression was
reached within 6 h (P  0.005; n  5; Fig. 1).
To test for thepresenceofDCLKat theprotein level,we
usedapolyclonal antiserumraisedagainstDCLK.Because
the epitopes are 100% conserved between mammals and
frog (Supplemental Fig. 2B), we used this antiserum to
specifically demonstrate Xenopus DCLK. Western blot
analysis ofNIL revealed a single band of 55 kDa (Fig. 2A),
corresponding to the predicted molecular mass of DCLK-
short (5, 27). Quantification of this product showed no
difference between the black and white adaptation states
(P  0.43; n  4; Fig. 2A).
With anti-p-DCLKserum,NIL fromblack-adapted an-
imals displayed a strong 55-kDa signal. The SSD of this
p-DCLK-short was more than 4 times higher in NIL of
black-adapted animals than white ones (P 0.01; n 4;
Fig. 2B). Incubating NIL of black-adapted animals for 1 d
in100MMEKinhibitorU0126didnot affect the amount
of the 55-kDaDCLK-short product (P 0.67; n 4; Fig.
2C) but reduced the amount of p-DCLK-short by 52%
(P 0.05; n 4; Fig. 2D). Treatment of the samples with
calf intestinal alkaline phosphatase (Promega Bioscience)
for 30 min had no noticeable effect on the amount of the
immunoreactivematerial as revealedwith anti-DCLKand
did not induce a shift in the molecular weight of the im-
munoreactive band but completely eliminated the immu-
noreactivity to anti-pDCLK (Supplemental Fig. 3).
To detect the source of p-DCLK-short in the NIL, we
studied the presence of the p-DCLK by immunohisto-
chemistry. In black-adapted animals, both the pars inter-
media and the pars nervosa showed strong staining (Fig.
3A). In white-adapted animals, however, the staining in
the pars intermedia was weaker (Fig. 3B,C; P 0.01; n
7), whereas the immunoreactivity of the pars nervosa did
not differ from that in theblack-adapted animals (Fig. 3B).
The presence of p-DCLK-immunoreactivity in single
melanotropes was studied in more detail by Cy3 fluores-
cence. Hoechst 33258was used as a nuclearmarker. Con-
focal images, in which fluorescence intensity was opti-
mized for a maximal Z-resolution, demonstrated that in
active melanotropes p-DCLK fluorescence was present
throughout the cytoplasmand thenucleus (Fig. 4A).How-
ever, in inactive melanotropes p-DCLK-fluorescence was
not seen in the nucleus but only in the cytoplasm (Fig. 4B).
This indicates that upon cell activation p-DCLK gets
translocated to the nucleus. We also observed that active
melanotropes were larger than inactive ones (Fig. 4),
which is consistent with earlier morphometry and ultra-
structural studies on intact NILs showing that the mela-
notropes in black-adapted animals are larger and have a
higher secretory activity than the melanotropes in white-
adapted animals (16).
FIG. 1. Q-RT-PCR of temporal dynamics of DCLK-short mRNA
amounts in the Xenopus laevis NIL during black adaptation. Increase in
mRNA starts 3 h after placing white-adapted animals (W) on a black
background and remains maximal from 6 h up to 24 h. NIL from
animals adapted for 3 wk to a black background (B) serve as controls.
Values represent means in arbitrary units (A.U.)  SEM (n  5). Letters
on top of bars indicate groups that are statistically different (P  0.05).
A B C D
FIG. 2. Western blots of DCLK-short (A and C) and p-DCLK-short (B and D). A and B, NIL from black- (B) and white (W)-adapted Xenopus (top
panels) and SSD of the 55-kDa (p-DCLK-short immunoreactive band) (lower panels). C and D, One day in vitro treatment of NIL from black-
adapted animals with control XL-L15 medium (C) or 100 M ERK inhibitor, U0126 (U). Values are means in arbitrary units (A.U.)  SEM (n  4).
Statistical difference was compared with black-adapted or control animals, respectively. *, P  0.05; **, P  0.01.
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Experiment 3: the role of the PTSP sequence in the
subcellular compartmentalization of p-DCLK-short
WT-DCLK-short transfected cells (n  80, from four
animals) displayed clear cytoplasmic GFP fluorescence
(Fig. 5A), and in about 50% of these cells, strong fluores-
cencewas also seen in the nucleus (Fig. 5B). In contrast, all
S/A-DCLK-short cells revealed only cytoplasmic GFP flu-
orescence (n 78 cells from four animals; Fig. 5B). After
treatment for 16 h with 100 M U0126, the percentage of
cells displaying nuclear fluorescence was only 24% of the
total number of transfected cells (P 0.001; n 73 cells
from four animals; Fig. 5B).
Experiment 4: the role of p-DCLK-short in POMC
mRNA expression
The effect of DCLK-short phosphorylation on POMC
mRNA transcription was assessed by single-cell Q-RT-
PCR, comparing control melanotropes transfected with
an EV with melanotropes in which either the WT- or the
S/A-DCLK-short construct was overexpressed. The Ct
values for GAPDH were 35.3  1.8, 35.2  1.4, and
35.4  1.9 for EV and WT- and S/A-DCLK-short trans-
fected cells, respectively. For POMC these values were
31.5  0.6, 29.1  0.8, and 33.0  1.1, respectively.
WT-DCLK-short-expressing melanotropes (n  11 cells,
three animals) revealed 60%more POMCmRNAexpres-
sion than control EV cells (n 12 cells, three animals;P
0.05; Fig. 6). POMC mRNA expression in S/A-DCLK-
short-expressing melanotropes did not significantly differ
from the controls (n 10 cells, three animals; P 0.07).
Expressionof POMCmRNA in S/Amelanotropeswas 2.2
times lower than in WT melanotropes (P  0.01; Fig. 6).
Discussion
We have investigated the possibility that DCLK-short is
involved in the control of POMC mRNA expression and
B
A
FIG. 3. Immunohistochemistry of p-DCLK in the Xenopus pituitary
gland. A, The pars intermedia (PI) is uniformly stained after black
adaptation (left panel) but only weakly stained after white adaptation
(right panel). PD, Pars distalis; PN, pars nervosa. Bars, 50 m. B, SSD of
p-DCLK-immunoreactive signal in pars intermedia (left panel) and pars
nervosa (right panel). Means are in arbitrary units (A.U.)  SEM (n  7).
*, Statistical difference compared with control (P  0.01).
A
B
FIG. 4. p-DCLK-short location in isolated melanotropes. Confocal
laser-scanning immunofluorescence microscopy of a single
melanotrope cell stained for p-DCLK (red) and Hoechst (blue) from a
black-adapted Xenopus (A) and from a white-adapted Xenopus (B).
Bars, 5 m.
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acts downstreamof ERK, using theXenopusmelanotrope
cell. This protein has been described in neurons and in the
endocrine-derived PC12 cell line (14), but our study is the
first showing the presence and in vivo regulation of
DCLK-short mRNA expression and DCLK-short protein
phosphorylation in a pituitary cell. Moreover, we show
for the first time that DCLK-short phosphorylation is as-
sociated with regulation of gene expression, in our case
with the stimulation of POMC. Alignment of the frog
DCLK-short amino acid sequence with that of mouse, hu-
man, and zebrafish reveals thatDCLK-short is highly con-
served among vertebrate classes. In particular, the N-ter-
minal region, containing the ERK phosphorylation
domain PTSP with a serine at position 30, and large parts
of the C-terminal catalytic domain, including the nuclear
retention sequence at residues 393–396, are conserved be-
tween the frog and the mammalian species. This may in-
dicate that DCLK-short has an important function in cel-
lular signaling throughout vertebrate evolution. We have
exploited the well-describedXenopusmelanotrope cell to
gain insight into the function of DCLK-short. Below we
discuss the outcomes of our experiments with particular
reference to the possibility that p-DCLK-short acts as a
downstream intranuclear effector of ERK signaling and
plays a role in POMC expression.
DCLK-short is expressed in melanotrope cells
Our Q-RT-PCR analysis revealed the presence of
DCLK-short mRNA in the Xenopus NIL. Because this
mRNA was very rapidly up-regulated after placing ani-
mals from a white to a black background (within 3 h),
DCLK-short may be an important factor in early melano-
trope cell activation, possibly acting as an immediate ef-
fector gene. Furthermore, the fact that the transcription of
DCLK-short is still activated after 3 wk of black adapta-
tion strongly suggests that the gene plays a role in the
maintenance of the active state of the melanotropes. Pre-
vious in vitro studies with mammalian cell lines link
DCLK-short expression to neurotrophins (10, 14). Possi-
bly, also in Xenopus melanotropes, BDNF signaling is
involved in DCLK-short expression because melanotrope
cells produce endogenous BDNF and express its receptors
(19, 28, 29).
Our data reveal that phosphorylation at the Ser-30 po-
sition of DCLK-short in melanotrope cells is coupled to
physiological adaptation of the animal to a black back-
ground.As theWesternblot analysis demonstrates, Ser-30
p-DCLK-short is strongly up-regulated in black-adapted
animals, whereas the total amount of (unphosphorylated
plus phosphorylated)DCLK-short is not affected by back-
ground adaptation.
These results differ from the strong up-regulation of
DCLK-short mRNA during background adaptation. Ap-
parently transcription and translation are not one to one
coupled. A possible explanation for this discrepancy is
protein turnover, whereby increased expression of the
mRNA is not paralleled by an increase in total protein
content. The fact that the strong phosphorylation of
DCLK-short seen in melanotropes of black-adapted ani-
mals was inhibited by theMEK inhibitor U0126 indicates
that DCLK-short is a downstream signaling molecule of
the ERK signal cascade. This notion is supported by our in
vitro studyof purified recombinantDCLK-short, showing
that WT-DCLK-short is strongly phosphorylated upon
FIG. 6. Q-RT-PCR reveals stimulatory effect of DCLK-short on
POMC mRNA expression. WT-DCLK-short expressing melanotropes
(WT; n  11) reveal more expression than control EV-transfected
cells (n  12) and S/A-DCLK-short expressing cells (n  10). *, P 
0.05; **, P  0.01.
B
A
FIG. 5. Effect of S/A mutation and U0126 incubation on presence of
DCLK-short in nucleus of melanotrope cells from black-adapted
animals. A, Confocal laser-scanning fluorescence microscopy of GFP-
labeled WT-DCLK-short in both cytoplasm and nucleus and in
cytoplasm only of S/A mutant DCLK-short and WT-DCLK-short treated
for 3 d with 10 M U0126 (U). Bars, 5 m. B, Percentage of
melanotrope cells displaying GFP fluorescence in the nucleus for WT-
DCLK-short (WT; n  80 cells), S/A-DCLK-short (S/A; n  78 cells), and
WT-DCLK-short after treatment with 10 M U0126 (U; n  73 cells)
(mean  SEM). All three groups differ statistically significantly from
each other (P  0.001).
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recombinant ERK application. Quantification of the de-
gree of p-DCLK immunoreactivity shows that in contrast
to the situation in the melanotrope cells in the pars inter-
media,DCLKphosphorylation in the adjacent neural lobe
does not depend on the background light condition. This
observation supports the conclusion that p-DCLK-short
has a specific role in the melanotrope cell during black
background adaptation.
Studies on mammalian cell lines have shown the in-
tranuclear presence of DCLK-short (7, 13, 27). Our im-
munocytochemistry of singlemelanotropes places this ob-
servation in a physiological context. Whereas in active
melanotropes p-DCLK-short is present in both the cyto-
plasm and nucleus, in inactive melanotropes p-DCLK-
short is present only in the cytoplasm. This observation
indicates that cell activation is associatedwith transport of
p-DCLK-short from the cytoplasm into nucleus and sug-
gests that the phosphorylated kinase is involved in the
regulation of gene expression.
Phosphorylation of Ser-30 is required for nuclear
DCLK-short translocation
We examined whether the predicted Ser-30 ERK phos-
phorylation site ofDCLK-short is involved in the protein’s
nuclear translocation. For this purpose, we expressed two
GFP-DCLK-short constructs in active melanotropes,
namely a WT-DCLK-short and an S/A-point mutant
DCLK-short in which Ser-30 of the PTSP sequence had
been replaced by an alanine residue. Because GFP fluo-
rescence microscopy showed that WT-DCLK-short oc-
curred in both the melanotrope cytoplasm and nucleus,
whereas S/A-DCLK-short was present only in the cyto-
plasm, we conclude that phosphorylation of Ser-30 in the
PTSP sequence is required for the nuclear translocation of
DCLK-short. The results also imply that DCLK-short
phosphorylation occurs in the cytoplasm, after which the
phosphorylated kinase translocates to the nucleus. Be-
cause treatment of WT-DCLK-short melanotropes with
theMEK inhibitor U0126 largely prevents the occurrence
of p-DCLK in the nucleus, p-ERK-mediated phosphory-
lation of Ser-30 apparently is required for nuclear trans-
location of p-DCLK-short. Upon U0126 treatment, some
nuclear GFP fluorescence was still visible in a minority
(24%) of cells. This fluorescence may be, at least partly,
due to incomplete inhibition of ERK-dependent phos-
phorylation, but it may also be due to the known capa-
bility of DCLK to autophosphorylate in an ERK-indepen-
dent way (1, 30). Such autophosphorylated DCLKwould
then translocate into the nucleus. The fact that only 50%
of the WT-DCLK-short cells displayed nuclear transloca-
tionmay be related to the notion that amphibian pituitary
melanotrope cells exhibit heterogeneity as to their secre-
tory activity (16, 31, 32).
p-DCLK-short stimulates POMC transcription
Because ERK has been implicated in expression of
POMC (33), and in melanotropes this expression is in-
hibited by theMEK inhibitor U0126 (34), we entertained
the idea that p-DCLK-short is a downstream effector of
the ERK pathway, for the purpose of regulating the ex-
pression of POMC.We thus investigated a possible role of
p-DCLK-short in POMC expression. To relate the effect
of transfection, visualized byGFP fluorescence, directly to
cellular gene expressionactivity,weappliedQ-RT-PCRto
single melanotropes. In cells expressing the WT-DCLK-
short construct POMC mRNA expression was markedly
increased comparedwith controls,whereas in S/A-DCLK-
short expressing cells an (nonsignificant) inhibitory trend
in POMC expression was found. Overexpression of the
S/Amutant in theory should haveworked as a competitive
inhibitor of endogenous DCLK-short. Possibly, the inclu-
sion of GFP in the protein reduces its biological activity.
Irrespective of this, the results of our experiments with the
WT-DCLK construct indicate that phosphorylation of
DCLK-short at the Ser-30 is necessary for the kinase to
translocate to the nucleus.
Conclusions
Our studies show that p-DCLK-short acts as a down-
stream intranuclear effector of ERK signaling inXenopus
melanotrope cells and demonstrate that, in this role, the
kinase is involved in the regulation of POMC expression.
Although several proteins have been shown to be phos-
phorylated by DCLK-short (6, 30), our report is the first
to show that nuclear localized p-DCLK-short is involved
in the regulation of a functional secretory gene, POMC.
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